Please enable JavaScript to continue using this application.

Compare $ELDN vs $RNAC | Chartloom

Compare

$ELDN vs $RNAC

Eledon Pharmaceuticals Inc · Cartesian Therapeutics Inc

ELDN

Eledon Pharmaceuticals Inc

RNAC

Cartesian Therapeutics Inc

Compare $ELDN vs $RNAC

Comparing Eledon Pharmaceuticals Inc and Cartesian Therapeutics Inc

ELDNEledon Pharmaceuticals Inc

RNACCartesian Therapeutics Inc

ELDNEledon Pharmaceuticals Inc

Market cap

$191M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

53.1%

52W performance

-13.6%

FCF yield

-38.6%

RNACCartesian Therapeutics Inc

Market cap

$207M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

473.62x

Rev growth (TTM)

-20.7%

YTD performance

4.4%

52W performance

-31.0%

FCF yield

-37.9%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

ELDN

RNAC

Detailed metrics comparison

ELDN

Eledon Pharmaceuticals Inc

RNAC

Cartesian Therapeutics Inc

Market Cap

ELDN$191M

RNAC$207M

Enterprise Value

ELDN$185M

RNAC$113M

Price

ELDN$2.48

RNAC$7.06

P/E Ratio

ELDNN/A

RNACN/A

P/S Ratio

ELDN0.00x

RNAC140.34x

EV/Sales

ELDN0.00x

RNAC76.18x

EV/EBITDA

ELDN0.00x

RNAC0.00x

P/B Ratio

ELDN2.81x

RNAC296.12x

P/FCF Ratio

ELDNN/A

RNACN/A

EV/FCF

ELDN-2.50x

RNAC-1.43x

PEG Ratio

ELDNN/A

RNACN/A

Forward P/E (NTM)

ELDNN/A

RNACN/A

Forward P/S (NTM)

ELDNN/A

RNAC473.62x

Revenue (TTM)

ELDN$0

RNAC$1M

Revenue Growth (YoY)

ELDNN/A

RNAC-20.7%

Forward Rev Growth

ELDN325.8%

RNAC-14.0%

Gross Margin (TTM)

ELDN0.0%

RNAC0.0%

Operating Margin (TTM)

ELDN0.0%

RNAC0.0%

EBITDA Margin (TTM)

ELDN0.0%

RNAC-6503.1%

Net Margin (TTM)

ELDN0.0%

RNAC-10422.5%

FCF Margin (TTM)

ELDNN/A

RNAC-5322.4%

Net Income (TTM)

ELDN$-99M

RNAC$-154M

FCF (TTM)

ELDN$-74M

RNAC$-79M

EPS (TTM)

ELDN-$0.87

RNAC-$5.16

ROE (TTM)

ELDN-9848.0%

RNAC-321582.0%

ROA (TTM)

ELDN-6897.0%

RNAC-4761.0%

ROIC (TTM)

ELDN-9848.0%

RNAC-321582.0%

Cash

ELDN$7M

RNAC$148M

Debt

ELDN$0

RNAC$53M

Net Cash/Debt

ELDN$7M

RNAC$95M

Current Ratio (TTM)

ELDN7.90x

RNAC7.48x

Quick Ratio (TTM)

ELDN7.60x

RNAC7.19x

Debt/Equity (TTM)

ELDN0.00x

RNAC0.28x

Debt/Assets (TTM)

ELDN0.0%

RNAC0.0%

Interest Coverage (TTM)

ELDNN/A

RNACN/A

Net Debt/EBITDA (TTM)

ELDN0.00x

RNAC0.00x

Beta

ELDN1.01

RNAC0.74

52W Performance

ELDN-13.6%

RNAC-31.0%

YTD Performance

ELDN53.1%

RNAC4.4%

% from 52W High

ELDN-46.1%

RNAC-35.9%

% from 52W Low

ELDN83.7%

RNAC26.0%

Asset Turnover (TTM)

ELDN0.00x

RNAC0.01x

FCF Yield (TTM)

ELDN-38.6%

RNAC-37.9%

Earnings Yield (TTM)

ELDN-51.5%

RNAC-74.3%

Dividend Yield (TTM)

ELDNN/A

RNACN/A

Rule of 40

ELDN0.0

RNAC-5,343.1

EV/GP/RG

ELDNN/A

RNACN/A

Ticker research

View ELDN research View RNAC research

Metric	ELDN Eledon Pharmaceuticals Inc	RNAC Cartesian Therapeutics Inc
Market & Valuation
Market Cap	$191M	$207M
Enterprise Value	$185M	$113M
Price	$2.48	$7.06
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	140.34x
EV/Sales	0.00x	76.18x
EV/EBITDA	0.00x	0.00x
P/B Ratio	2.81x	296.12x
P/FCF Ratio	N/A	N/A
EV/FCF	-2.50x	-1.43x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	473.62x
Revenue & Growth
Revenue (TTM)	$0	$1M
Revenue Growth (YoY)	N/A	-20.7%
Forward Rev Growth	325.8%	-14.0%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-6503.1%
Net Margin (TTM)	0.0%	-10422.5%
FCF Margin (TTM)	N/A	-5322.4%
Net Income (TTM)	$-99M	$-154M
FCF (TTM)	$-74M	$-79M
EPS (TTM)	-$0.87	-$5.16
ROE (TTM)	-9848.0%	-321582.0%
ROA (TTM)	-6897.0%	-4761.0%
ROIC (TTM)	-9848.0%	-321582.0%
Financial Health
Cash	$7M	$148M
Debt	$0	$53M
Net Cash/Debt	$7M	$95M
Current Ratio (TTM)	7.90x	7.48x
Quick Ratio (TTM)	7.60x	7.19x
Debt/Equity (TTM)	0.00x	0.28x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.01	0.74
52W Performance	-13.6%	-31.0%
YTD Performance	53.1%	4.4%
% from 52W High	-46.1%	-35.9%
% from 52W Low	83.7%	26.0%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.01x
FCF Yield (TTM)	-38.6%	-37.9%
Earnings Yield (TTM)	-51.5%	-74.3%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	-5,343.1
EV/GP/RG	N/A	N/A
Ticker research	View ELDN research	View RNAC research

Valuation

P/S Ratio

ELDN

0.00x

RNAC

140.34x

EV/FCF

ELDN

-2.50x

RNAC

-1.43x

Growth & revenue

Revenue Growth TTM

RNAC

-20.7%

Forward Revenue Growth

ELDN

325.8%

RNAC

-14.0%

Profitability & performance

Gross Margin

ELDN

0.0%

RNAC

0.0%

ROE

ELDN

-9848.0%

RNAC

-321582.0%

FCF Yield %

RNAC

-37.9%

ELDN

-38.6%

52-Week Performance

ELDN

-13.6%

RNAC

-31.0%

Detailed metrics comparison

ELDN

Eledon Pharmaceuticals Inc

RNAC

Cartesian Therapeutics Inc

Market Cap

ELDN$191M

RNAC$207M

Enterprise Value

ELDN$185M

RNAC$113M

Price

ELDN$2.48

RNAC$7.06

P/E Ratio

ELDNN/A

RNACN/A

P/S Ratio

ELDN0.00x

RNAC140.34x

EV/Sales

ELDN0.00x

RNAC76.18x

EV/EBITDA

ELDN0.00x

RNAC0.00x

P/B Ratio

ELDN2.81x

RNAC296.12x

P/FCF Ratio

ELDNN/A

RNACN/A

EV/FCF

ELDN-2.50x

RNAC-1.43x

PEG Ratio

ELDNN/A

RNACN/A

Forward P/E (NTM)

ELDNN/A

RNACN/A

Forward P/S (NTM)

ELDNN/A

RNAC473.62x

Revenue (TTM)

ELDN$0

RNAC$1M

Revenue Growth (YoY)

ELDNN/A

RNAC-20.7%

Forward Rev Growth

ELDN325.8%

RNAC-14.0%

Gross Margin (TTM)

ELDN0.0%

RNAC0.0%

Operating Margin (TTM)

ELDN0.0%

RNAC0.0%

EBITDA Margin (TTM)

ELDN0.0%

RNAC-6503.1%

Net Margin (TTM)

ELDN0.0%

RNAC-10422.5%

FCF Margin (TTM)

ELDNN/A

RNAC-5322.4%

Net Income (TTM)

ELDN$-99M

RNAC$-154M

FCF (TTM)

ELDN$-74M

RNAC$-79M

EPS (TTM)

ELDN-$0.87

RNAC-$5.16

ROE (TTM)

ELDN-9848.0%

RNAC-321582.0%

ROA (TTM)

ELDN-6897.0%

RNAC-4761.0%

ROIC (TTM)

ELDN-9848.0%

RNAC-321582.0%

Cash

ELDN$7M

RNAC$148M

Debt

ELDN$0

RNAC$53M

Net Cash/Debt

ELDN$7M

RNAC$95M

Current Ratio (TTM)

ELDN7.90x

RNAC7.48x

Quick Ratio (TTM)

ELDN7.60x

RNAC7.19x

Debt/Equity (TTM)

ELDN0.00x

RNAC0.28x

Debt/Assets (TTM)

ELDN0.0%

RNAC0.0%

Interest Coverage (TTM)

ELDNN/A

RNACN/A

Net Debt/EBITDA (TTM)

ELDN0.00x

RNAC0.00x

Beta

ELDN1.01

RNAC0.74

52W Performance

ELDN-13.6%

RNAC-31.0%

YTD Performance

ELDN53.1%

RNAC4.4%

% from 52W High

ELDN-46.1%

RNAC-35.9%

% from 52W Low

ELDN83.7%

RNAC26.0%

Asset Turnover (TTM)

ELDN0.00x

RNAC0.01x

FCF Yield (TTM)

ELDN-38.6%

RNAC-37.9%

Earnings Yield (TTM)

ELDN-51.5%

RNAC-74.3%

Dividend Yield (TTM)

ELDNN/A

RNACN/A

Rule of 40

ELDN0.0

RNAC-5,343.1

EV/GP/RG

ELDNN/A

RNACN/A

Ticker research

View ELDN research View RNAC research

Metric	ELDN Eledon Pharmaceuticals Inc	RNAC Cartesian Therapeutics Inc
Market & Valuation
Market Cap	$191M	$207M
Enterprise Value	$185M	$113M
Price	$2.48	$7.06
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	140.34x
EV/Sales	0.00x	76.18x
EV/EBITDA	0.00x	0.00x
P/B Ratio	2.81x	296.12x
P/FCF Ratio	N/A	N/A
EV/FCF	-2.50x	-1.43x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	473.62x
Revenue & Growth
Revenue (TTM)	$0	$1M
Revenue Growth (YoY)	N/A	-20.7%
Forward Rev Growth	325.8%	-14.0%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-6503.1%
Net Margin (TTM)	0.0%	-10422.5%
FCF Margin (TTM)	N/A	-5322.4%
Net Income (TTM)	$-99M	$-154M
FCF (TTM)	$-74M	$-79M
EPS (TTM)	-$0.87	-$5.16
ROE (TTM)	-9848.0%	-321582.0%
ROA (TTM)	-6897.0%	-4761.0%
ROIC (TTM)	-9848.0%	-321582.0%
Financial Health
Cash	$7M	$148M
Debt	$0	$53M
Net Cash/Debt	$7M	$95M
Current Ratio (TTM)	7.90x	7.48x
Quick Ratio (TTM)	7.60x	7.19x
Debt/Equity (TTM)	0.00x	0.28x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.01	0.74
52W Performance	-13.6%	-31.0%
YTD Performance	53.1%	4.4%
% from 52W High	-46.1%	-35.9%
% from 52W Low	83.7%	26.0%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.01x
FCF Yield (TTM)	-38.6%	-37.9%
Earnings Yield (TTM)	-51.5%	-74.3%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	-5,343.1
EV/GP/RG	N/A	N/A
Ticker research	View ELDN research	View RNAC research